Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...
Month: September 2023
Personalized Analysis From Breath Hub Redefines the Power of Breathwork
New research from the only app offering personalized breathwork analysis proves a science-based approach is the quickest way to help...
Constellation Behavioral Health Welcomes New Executive Vice President of Business Development Rick Hubbard
Rick is an advocate, mentor, and trusted advisor with national reach, and we are thrilled to welcome him to our...
Calm Waters AI Named Finalist for 2023 Technology Startup Award
NASHVILLE, Tenn.--(BUSINESS WIRE)--Calm Waters AI—an AI-driven technology solution that optimizes Evaluation and Management (E/M) coding for healthcare providers—has been named...
Walgreens Boots Alliance Announces Leadership Transition
Rosalind Brewer Steps Down as CEO and Member of the Board Ginger Graham, Current Lead Independent Director, Appointed Interim CEO...
Nexcella Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma...
Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma...
Globus Medical Completes Merger with NuVasive
—Creates leading global musculoskeletal company——Robust portfolio well-positioned for long-term growth and continued innovation— AUDUBON, Pa., Sept. 01, 2023 (GLOBE NEWSWIRE)...
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher diseaseCould...
Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
Fort Lee, NJ, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
Psyched Wellness Closes Tranche 2A of Non-Brokered Private Placement, Amends and Restates Investor Rights Agreement, Provides Corporate Update and Announces Director Change
Toronto, Ontario--(Newsfile Corp. - September 1, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
GENEVA, SWITZERLAND / ACCESSWIRE / September 1, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics), a biopharmaceutical company committed...